Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Bausch Health Companies Inc       CA91911K1021

BAUSCH HEALTH COMPANIES INC

 SummaryChartsNewsRatingsCalendarCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
07/09/2018 07/10/2018 07/11/2018 07/12/2018 07/13/2018 Date
30.88 31.18 31.36 31.86 30.8 Last
1078107 1018037 1331258 848750 1232408 Volume
+2.73% +0.97% +0.58% +1.59% -3.33% Change
Company
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas... 
Sector
Pharmaceuticals
Calendar
02/19Earnings Release
More about the company
Surperformance© ratings of Bausch Health Companies In
Trading Rating : Investor Rating :
More Ratings
Latest news on BAUSCH HEALTH COMPANIES IN
02/19BAUSCH HEALTH : Management's Discussion and Analysis of Financial Condition and ..
AQ
02/19Health Care Up Amid Mixed Earnings -- Health Care Roundup
DJ
02/19BAUSCH HEALTH COMPANIES INC. : Triggering Events That Accelerate or Increase a D..
AQ
02/19BAUSCH HEALTH : Announces It Is Seeking A Refinancing Amendment To Its Existing ..
AQ
02/19TSX rises 0.38% to 17,925.36
RE
02/19NEWS HIGHLIGHTS : Top Company News of the Day
DJ
02/19NEWS HIGHLIGHTS : Top Company News of the Day
DJ
02/19NEWS HIGHLIGHTS : Top Company News of the Day
DJ
02/19NEWS HIGHLIGHTS : Top Company News of the Day
DJ
02/19BAUSCH HEALTH COMPANIES INC : . - Ortho Dermatologics Launches Telemedicine on D..
AQ
02/19BAUSCH HEALTH : reports US$1.52B Q4 loss due to stock drop lawsuit settlement
AQ
02/19BAUSCH : 4Q Earnings Snapshot
AQ
02/19BAUSCH HEALTH COMPANIES INC. : Results of Operations and Financial Condition (fo..
AQ
02/18BAUSCH HEALTH : Ortho Dermatologics Launches Telemedicine on Dermatology.com, U...
AQ
02/14BAUSCH HEALTH COMPANIES INC. : annual earnings release
More news
News in other languages on BAUSCH HEALTH COMPANIES IN
02/14BAUSCH HEALTH COMPANIES INC. : Veröffentlichung des Jahresergebnisses
02/14BAUSCH HEALTH COMPANIES INC. : publication des résultats annuels
01/11Behält Warren Buffett am Ende doch recht?
2018WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
2018WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
More news
Analyst Recommendations on BAUSCH HEALTH COMPANIES IN
More recommendations
Sector news : Pharmaceuticals - NEC
01:46pEXCLUSIVE : Canadian regulator considers changes to new drug pricing plan
RE
01:26pFresenius forecasts 2020 profit growth driven by drug, dialysis units
RE
11:38aSHANGHAI FOSUN PHARMACEUTICAL : banks issue 1.31 billion yuan in cheap loans to ..
RE
10:35aDAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
09:50aALLERGAN : Form 8.3 - Allergan Plc
DJ
More sector news : Pharmaceuticals - NEC
Chart BAUSCH HEALTH COMPANIES INC
Duration : Period :
Bausch Health Companies Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Joseph C. Papa Chairman & Chief Executive Officer
Paul S. Herendeen Chief Financial Officer & Executive Vice President
Tage Ramakrishna Chief Medical Officer, President-R&D
Robert N. Power Independent Director
David Robert Hale Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BAUSCH HEALTH COMPANIES INC23.86%9 325
JOHNSON & JOHNSON2.24%392 415
ROCHE HOLDING AG10.05%303 192
NOVARTIS3.81%220 641
MERCK AND COMPANY-9.84%208 771
PFIZER-7.30%200 501